Skip to main content
OpenTrials
Completed

NCT Number: NCT02900287

Cancer Survival in Reunion Island , 1998-2008 (SUCRE)

Cancer survival is important to determine prognostic of patients and evaluate care and prevention health strategies. Sucre is the first study to describe cancer survival in Reunion Island. Sucre aims at evaluating five year cancer prognostic in Reunion Island by cancer site and gender. Sucre is a retrospective cohort study of cancer diagnosed between 01/01/1998 and 31/12/2008.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neoplasms

Age range

15 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de La Réunion

Saint-Denis, 97400, Reunion

About this study

Data are extracted from Reunion Island Cancer Registry.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients domiciled in Reunion Island at diagnosis
  • Patients with at least 15 years of age at diagnosis
  • Patients with cancer diagnosis between 01/01/1998 and 31/12/2008

Exclusion criteria

  • Cutaneous malignant cancer expected melanoma

Treatment and study plan

Primary outcomes

  1. 5 years related survival rate by cancer site and gender

    Time frame: 5 years

Secondary outcomes

  1. 1, 3, 5 and 10 years related survival rate by cancer site and gender

    Time frame: 1, 3, 5 and 10 years

  2. 1, 3, 5 and 10 years standardised survival rate by cancer site and gender

    Time frame: 1, 3, 5 and 10 years

  3. 1, 3, 5 and 10 years related survival rate by age at diagnosis

    Time frame: 1, 3, 5 and 10 years

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de la Réunion

Other

Registry information

Official study title

Survie Des Personnes Atteintes de Cancer à la Réunion, 1998-2008 (SUCRE)

Acronym: SUCRE

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Sep 14, 2016
Registry last updated
Jan 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.